Crit Care. 2008;12 Suppl 4:S4. Epub 2008 May 21
Contents of Volume 12 Suppl 4
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
优化应用碳青霉烯类抗生素应对日益增加的革兰阴性细菌的耐药性
Reviews
Edited by Stephan Harbarth
Publication of this supplement has been sponsored by Ortho-McNeil, Inc.
Additional information
Introduction
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Reuben Ramphal
Critical Care 2008, 12(Suppl 4):S1 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]
Review
Pharmacodynamic optimization of β-lactams in the patient care setting
David P Nicolau
Critical Care 2008, 12(Suppl 4):S2 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]
Review
An overview of harms associated with β-lactam antimicrobials: where do the carbapenems fit in?
Robert C Owens Jr
Critical Care 2008, 12(Suppl 4):S3 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]
Review
Gram-negative antibiotic resistance: there is a price to pay
Thomas G Slama
Critical Care 2008, 12(Suppl 4):S4 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]
Review
The role of carbapenems in initial therapy for serious Gram-negative infections
James J Rahal
Critical Care 2008, 12(Suppl 4):S5 (21 May 2008)
[Full text] [PDF] [PubMed] [Related articles]